ĢƵ

Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy...

Alan Evans receives Order of Canada

Published: 30 June 2025

Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honours ...

Sunsetting of the Vanier and Banting programs

Published: 10 February 2025

In alignment with the Tri-Agency Research Training Strategy and as announced in Budget 2024, the three federal granting agencies, the Canadian Institutes of Health Research (CIHR), the Natural...

ĢƵ Cares: Building your team for unplanned life transitions

Published: 15 April 2025

Join us on May 7th at noon for the next ĢƵ Cares webcast to support informal caregivers. During candid, interviews with leading experts, Claire Webster explores topics related to caring for a...

SCSD Research Day

Published: 10 February 2025

Friday February 21st 2025 • 3pm to 5pm Leacock Building #232, 855 Sherbrooke West  

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

Published: 26 March 2025

Montreal, March 26, 2025 – ĢƵ’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based...

ĢƵ’s President honours outstanding early-career researchers

Published: 29 May 2025

Professors Guojun Chen, Mahsa Dadar and Phoebe Friesen – all members of the Faculty of Medicine and Health Sciences – win President’s Prize for Outstanding Emerging Researchers  ...

Pages

Back to top